ARCHIVES

Academic Oncologists Losing Control Over Phase I Trials As For-Profits Expand

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | March 26, 2010

Download PDF Visit The Full Archive

Related Articles

The Line Item for Cancer Centers and SPOREs to Remain Flat, Near $598 Million for the 2013 Fiscal Year

April 20, 2012

NCI, SAIC To Support Contracts For Molecular Target Labs.

February 25, 2000

Organizations Ask Senate To Increase NCI Appropriations, Order OMB To “Get Nose Out Of Tent”

May 2, 1986

Andrew von Eschenbach Sworn In As NCI Director.

January 25, 2002

Judge Hears Arguments In Fisher’s Privacy Act Suit Over Databases

January 19, 1996

“Absurd” Budget Cuts Would Devastate Cancer Program, Slash NCI Funds By $125 Million

December 6, 1974